Literature DB >> 11124290

Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis.

S R Sanislo1, C Y Lowder, P K Kaiser, F A Gutman, H Zegarra, E M Dodds, J P Dailey, D M Meisler, E T Cunningham.   

Abstract

PURPOSE: To report successful corticosteroid treatment of optic disc neovascularization associated with uveitis.
METHODS: Retrospective review of medical records.
RESULTS: Nine patients were identified with chronic uveitis and optic disc neovascularization without clinical or angiographic evidence of retinal ischemia. Ages ranged from 14 to 37 years (median age, 27). All patients were treated with either oral and/or subtenon's corticosteroids. Partial regression of the neovascularization was observed in all patients within 2 to 6 weeks (median, 5 weeks) after initiating treatment. Eight of nine patients had complete resolution of disc neovascularization at a median of 3 months (range, 2 to 42 months) after initiation of treatment and a median follow-up of 24 months (range, 7 to 144 months). Recurrence of disc neovascularization occurred in two patients, but it regressed again after further corticosteroid therapy.
CONCLUSIONS: Optic disc neovascularization may occur in patients with chronic uveitis in the absence of retinal ischemia. This neovascularization can be successfully treated with corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124290     DOI: 10.1016/s0002-9394(00)00598-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Risk of Retinal Neovascularization in Cases of Uveitis.

Authors:  Apurva K Patel; Craig W Newcomb; Teresa L Liesegang; Siddharth S Pujari; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; H Nida Sen; Pichaporn Artornsombudh; Srishti Kothari; John H Kempen
Journal:  Ophthalmology       Date:  2015-12-11       Impact factor: 12.079

2.  Neovascularization of the optic disc in Behçet's disease.

Authors:  Ilknur Tugal-Tutkun; Sumru Onal; Rana Altan-Yaycioglu; Nur Kir; Meri Urgancioglu
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

3.  Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy.

Authors:  Abdourahman Cham; Mayank Bansal; Himanshu K Banda; Young Kwon; Paul S Tlucek; Alexander G Bassuk; Stephen H Tsang; Warren M Sobol; James C Folk; Steven Yeh; Vinit B Mahajan
Journal:  Clin Ophthalmol       Date:  2016-06-27

4.  Recurrent neovascularization of the disc in sympathetic ophthalmia.

Authors:  Raju Sampangi; Pradeep Venkatesh; Subrata Mandal; Sat Paul Garg
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.